Found 825 with Last Name = 'hendricks' and Initial = 'rt' 
Affinity DataKi: 0.700nMAssay Description:Binding affinity to human EP4 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 0.940nMAssay Description:Binding affinity to human EP4 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 1nMAssay Description:Binding affinity to human EP4 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 2.90nMAssay Description:Binding affinity to human EP4 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 3.80nMAssay Description:Binding affinity to human EP4 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 4.5nMAssay Description:Binding affinity to human EP4 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 6.90nMAssay Description:Binding affinity to human EP4 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 7nMAssay Description:Binding affinity to human EP4 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 17nMAssay Description:Binding affinity to human EP4 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 18nMAssay Description:Binding affinity to human EP4 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 35nMAssay Description:Binding affinity to human EP2 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 75nMAssay Description:Binding affinity to human EP2 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 130nMAssay Description:Binding affinity to human EP2 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 220nMAssay Description:Binding affinity to human EP2 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 530nMAssay Description:Binding affinity to human EP4 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 900nMAssay Description:Binding affinity to human EP4 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 1.90E+3nMAssay Description:Binding affinity to human EP3 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 2.50E+3nMAssay Description:Binding affinity to human EP2 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 3.70E+3nMAssay Description:Binding affinity to human EP2 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 4.70E+3nMAssay Description:Binding affinity to human EP2 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 5.10E+3nMAssay Description:Binding affinity to human EP2 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 1.10E+4nMAssay Description:Binding affinity to human EP3 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 1.80E+4nMAssay Description:Binding affinity to human EP1 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 5.40E+4nMAssay Description:Binding affinity to human EP3 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 7.70E+4nMAssay Description:Binding affinity to human EP3 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 7.90E+4nMAssay Description:Binding affinity to human EP3 receptorMore data for this Ligand-Target Pair
Affinity DataKi: 9.03E+4nMAssay Description:Binding affinity to human EP3 receptorMore data for this Ligand-Target Pair
Affinity DataKi: >1.00E+5nMAssay Description:Binding affinity to human EP3 receptorMore data for this Ligand-Target Pair
Affinity DataKi: >1.00E+5nMAssay Description:Binding affinity to human EP3 receptorMore data for this Ligand-Target Pair
Affinity DataKi: >1.00E+5nMAssay Description:Binding affinity to human EP1 receptorMore data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/WS/1933 H1N1))
Janssen Biopharma
US Patent
Janssen Biopharma
US Patent
Affinity DataIC50: 0.400nMAssay Description:EN PA FRET inhibition assay was performed using a 19 nucleotide synthetic oligoribonucleotide substrate: 5′-FAM-AUUUUGUUUUUAAUAUUUC-BHQ-3′...More data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/WS/1933 H1N1))
Janssen Biopharma
US Patent
Janssen Biopharma
US Patent
Affinity DataIC50: 1nMAssay Description:EN PA FRET inhibition assay was performed using a 19 nucleotide synthetic oligoribonucleotide substrate: 5′-FAM-AUUUUGUUUUUAAUAUUUC-BHQ-3′...More data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/WS/1933 H1N1))
Janssen Biopharma
US Patent
Janssen Biopharma
US Patent
Affinity DataIC50: 1nMAssay Description:EN PA FRET inhibition assay was performed using a 19 nucleotide synthetic oligoribonucleotide substrate: 5′-FAM-AUUUUGUUUUUAAUAUUUC-BHQ-3′...More data for this Ligand-Target Pair
Affinity DataIC50: 1nMAssay Description:Inhibition of HSV1b con1 NS5B polymerase assessed as [3H]UTP incorporation into acid insoluble RNA productMore data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/WS/1933 H1N1))
Janssen Biopharma
US Patent
Janssen Biopharma
US Patent
Affinity DataIC50: 1.20nMAssay Description:EN PA FRET inhibition assay was performed using a 19 nucleotide synthetic oligoribonucleotide substrate: 5′-FAM-AUUUUGUUUUUAAUAUUUC-BHQ-3′...More data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/WS/1933 H1N1))
Janssen Biopharma
US Patent
Janssen Biopharma
US Patent
Affinity DataIC50: 1.90nMAssay Description:EN PA FRET inhibition assay was performed using a 19 nucleotide synthetic oligoribonucleotide substrate: 5′-FAM-AUUUUGUUUUUAAUAUUUC-BHQ-3′...More data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/WS/1933 H1N1))
Janssen Biopharma
US Patent
Janssen Biopharma
US Patent
Affinity DataIC50: 2nMAssay Description:EN PA FRET inhibition assay was performed using a 19 nucleotide synthetic oligoribonucleotide substrate: 5′-FAM-AUUUUGUUUUUAAUAUUUC-BHQ-3′...More data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/WS/1933 H1N1))
Janssen Biopharma
US Patent
Janssen Biopharma
US Patent
Affinity DataIC50: 2nMAssay Description:EN PA FRET inhibition assay was performed using a 19 nucleotide synthetic oligoribonucleotide substrate: 5′-FAM-AUUUUGUUUUUAAUAUUUC-BHQ-3′...More data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/WS/1933 H1N1))
Janssen Biopharma
US Patent
Janssen Biopharma
US Patent
Affinity DataIC50: 2nMAssay Description:EN PA FRET inhibition assay was performed using a 19 nucleotide synthetic oligoribonucleotide substrate: 5′-FAM-AUUUUGUUUUUAAUAUUUC-BHQ-3′...More data for this Ligand-Target Pair
Affinity DataIC50: 2nMAssay Description:Inhibition of HSV 1b con1 NS5B polymerase assessed as [3H]UTP incorporation into acid insoluble RNA productMore data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/WS/1933 H1N1))
Janssen Biopharma
US Patent
Janssen Biopharma
US Patent
Affinity DataIC50: 2.40nMAssay Description:EN PA FRET inhibition assay was performed using a 19 nucleotide synthetic oligoribonucleotide substrate: 5′-FAM-AUUUUGUUUUUAAUAUUUC-BHQ-3′...More data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/WS/1933 H1N1))
Janssen Biopharma
US Patent
Janssen Biopharma
US Patent
Affinity DataIC50: 2.80nMAssay Description:EN PA FRET inhibition assay was performed using a 19 nucleotide synthetic oligoribonucleotide substrate: 5′-FAM-AUUUUGUUUUUAAUAUUUC-BHQ-3′...More data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/WS/1933 H1N1))
Janssen Biopharma
US Patent
Janssen Biopharma
US Patent
Affinity DataIC50: 3nMAssay Description:EN PA FRET inhibition assay was performed using a 19 nucleotide synthetic oligoribonucleotide substrate: 5′-FAM-AUUUUGUUUUUAAUAUUUC-BHQ-3′...More data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:Inhibition of HSV1b con1 NS5B polymerase assessed as [3H]UTP incorporation into acid insoluble RNA productMore data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:Inhibition of protein kinase C betaMore data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/WS/1933 H1N1))
Janssen Biopharma
US Patent
Janssen Biopharma
US Patent
Affinity DataIC50: 3nMAssay Description:EN PA FRET inhibition assay was performed using a 19 nucleotide synthetic oligoribonucleotide substrate: 5′-FAM-AUUUUGUUUUUAAUAUUUC-BHQ-3′...More data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/WS/1933 H1N1))
Janssen Biopharma
US Patent
Janssen Biopharma
US Patent
Affinity DataIC50: 3nMAssay Description:EN PA FRET inhibition assay was performed using a 19 nucleotide synthetic oligoribonucleotide substrate: 5′-FAM-AUUUUGUUUUUAAUAUUUC-BHQ-3′...More data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/WS/1933 H1N1))
Janssen Biopharma
US Patent
Janssen Biopharma
US Patent
Affinity DataIC50: 3nMAssay Description:EN PA FRET inhibition assay was performed using a 19 nucleotide synthetic oligoribonucleotide substrate: 5′-FAM-AUUUUGUUUUUAAUAUUUC-BHQ-3′...More data for this Ligand-Target Pair
TargetPolymerase basic protein 2(Influenza A virus (strain A/WS/1933 H1N1))
Janssen Biopharma
US Patent
Janssen Biopharma
US Patent
Affinity DataIC50: 3nMAssay Description:EN PA FRET inhibition assay was performed using a 19 nucleotide synthetic oligoribonucleotide substrate: 5′-FAM-AUUUUGUUUUUAAUAUUUC-BHQ-3′...More data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:Inhibition of HSV 1b con1 NS5B polymerase assessed as [3H]UTP incorporation into acid insoluble RNA productMore data for this Ligand-Target Pair
